MAX Chat
Company Analysis Bumrungrad Hospital Public Company Limited
1. Summary
Advantages
- Price (4.85 $) is less than fair price (9.96 $)
Disadvantages
- Dividends (2.84%) are below the sector average (4.22%).
- The stock's return over the last year (-42.26%) is lower than the sector average (0%).
- Current debt level 0.4257% has increased over 5 years from 0%.
- The company's current efficiency (ROE=1.84%) is lower than the sector average (ROE=10.25%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Bumrungrad Hospital Public Company Limited | Index | ||
|---|---|---|---|
| 7 days | 0% | 0.1% | -0.7% |
| 90 days | 0% | -20.6% | 9.7% |
| 1 year | -42.3% | 0% | 14.2% |
BUHPF vs Sector: Bumrungrad Hospital Public Company Limited has significantly underperformed the "" sector by -42.26% over the past year.
BUHPF vs Market: Bumrungrad Hospital Public Company Limited has significantly underperformed the market by -56.49% over the past year.
Stable price: BUHPF is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BUHPF with weekly volatility of -0.8127% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (4.85 $) is lower than the fair price (9.96 $).
Price significantly below the fair price: The current price (4.85 $) is 105.4% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (32.17) is lower than that of the sector as a whole (228.43).
P/E vs Market: The company's P/E (32.17) is lower than that of the market as a whole (157.85).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (9) is higher than that of the sector as a whole (4.81).
P/BV vs Market: The company's P/BV (9) is higher than that of the market as a whole (3.6).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (9.72) is lower than that of the sector as a whole (13.14).
P/S vs Market: The company's P/S indicator (9.72) is higher than that of the market as a whole (6.26).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (23.47) is higher than that of the sector as a whole (11.15).
EV/Ebitda vs Market: The company's EV/Ebitda (23.47) is higher than that of the market as a whole (14.87).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -16.01% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-16.01%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (1.84%) is lower than that of the sector as a whole (10.25%).
ROE vs Market: The company's ROE (1.84%) is lower than that of the market as a whole (206.46%).
5.5. ROA
ROA vs Sector: The company's ROA (1.5%) is higher than that of the sector as a whole (0.8377%).
ROA vs Market: The company's ROA (1.5%) is lower than that of the market as a whole (188.29%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (5.35%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 2.84% is below the average for the sector '4.22%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.84% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 2.84% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (52.75%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
